Results 1 to 10 of about 35,228 (288)

Biomimetic hydrogels with mesoscale collagen architecture for patient-derived tumor organoids culture [PDF]

open access: yesBioactive Materials
Patient-derived tumor organoids (PDTOs) shows great potential as a preclinical model. However, the current methods for establishing PDTOs primarily focus on modulating local properties, such as sub-micrometer topographies.
Jiaxin Wang   +4 more
doaj   +4 more sources

Patient-Derived Tumor Organoids: New Progress and Opportunities to Facilitate Precision Cancer Immunotherapy [PDF]

open access: yesFrontiers in Oncology, 2022
Cancer immunotherapy has revolutionized the field of cancer treatment in recent years. However, not all patients receiving cancer immunotherapy exhibit durable responses, and reliable, high-throughput testing platforms are urgently needed to guide ...
Ji Wang   +17 more
doaj   +2 more sources

Chinese experts consensus on quality control standards for tumor organoids diagnosis and treatment platform (2022 version) [PDF]

open access: yesZhongguo aizheng zazhi, 2022
Recently, advances in organoid technology have opened new avenues for the development of novel models of human cancer. Patient-derived tumor organoids retain phenotypes such as histopathological, genetic and molecular features of the original tumor.
The Society of Cancer Multidisciplinary Diagnosis and Treatment, China Anti-Cancer Association, The Society of Cancer Endocrinology, China Anti-Cancer Association
doaj   +1 more source

Normal and tumor-derived organoids as a drug screening platform for tumor-specific drug vulnerabilities

open access: yesSTAR Protocols, 2022
Summary: Patient-derived tumor organoids can be predictive of patient’s treatment responses, and normal tissue-derived organoids allow for drug toxicity testing.
Camilla Calandrini, Jarno Drost
doaj   +1 more source

Digital image analysis using video microscopy of human-derived prostate cancer vs normal prostate organoids to assess migratory behavior on extracellular matrix proteins

open access: yesFrontiers in Oncology, 2023
The advent of perpetuating living organoids derived from patient tissue is a promising avenue for cancer research but is limited by difficulties with precise characterization.
Kendra D. Marr   +10 more
doaj   +1 more source

Application Progress of Organoids in Colorectal Cancer

open access: yesFrontiers in Cell and Developmental Biology, 2022
Currently, colorectal cancer is still the third leading cause of cancer-related mortality, and the incidence is rising. It is a long time since the researchers used cancer cell lines and animals as the study subject. However, these models possess various
Lianxiang Luo   +6 more
doaj   +1 more source

Genetic characterization of a novel organoid from human malignant giant-cell tumor

open access: yesJournal of Bone Oncology, 2023
Malignant giant-cell tumors are extremely rare bone sarcomas that transform from conventional giant-cell tumors during long periods of treatment. Owing to their rarity, no further analysis of their molecular pathogenesis exists, and thus, no standard ...
Rie Suzuki   +13 more
doaj   +1 more source

Advances in Tumor Organoids for the Evaluation of Drugs: A Bibliographic Review

open access: yesPharmaceutics, 2022
Tumor organoids are defined as self-organized three-dimensional assemblies of heterogeneous cell types derived from patient samples that mimic the key histopathological, genetic, and phenotypic characteristics of the original tumor.
Maritza Londoño-Berrio   +4 more
doaj   +1 more source

Systematic evaluation of colorectal cancer organoid system by single-cell RNA-Seq analysis

open access: yesGenome Biology, 2022
Background Patient-derived organoid culture is a powerful system for studying the molecular mechanisms of cancers, especially colorectal cancer (CRC), one of the most prevalent cancers worldwide. There are two main types of 3D culture methods for colonic
Rui Wang   +9 more
doaj   +1 more source

An Organoid-Based Preclinical Model of Human Gastric CancerSummary

open access: yesCellular and Molecular Gastroenterology and Hepatology, 2019
Background & Aims: Our goal was to develop an initial study for the proof of concept whereby gastric cancer organoids are used as an approach to predict the tumor response in individual patients.
Nina G. Steele   +14 more
doaj   +1 more source

Home - About - Disclaimer - Privacy